For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241126:nRSZ5881Na&default-theme=true
RNS Number : 5881N Spire Healthcare Group PLC 26 November 2024
26 November 2024
Spire Healthcare Group plc
Transaction in own shares
Spire Healthcare Group plc (the "Company") announces that, in accordance with
the terms of its share buyback programme announced on 31 October 2024 (the
"Share Buyback Programme") and the authority granted by its shareholders at
the Company's 2024 Annual General Meeting held on 9 May 2024, it has purchased
the following number of its ordinary shares of 1 pence each ("Shares") on the
London Stock Exchange through Numis Securities Limited ("Deutsche Numis"):
Date of purchase: 25 November 2024
Number of Shares purchased: 38,981
Highest price paid per Share (GBp): 220.00
Lowest price paid per Share (GBp): 217.50
Volume weighted average price paid per Share (GBp): 218.7705
Broker: Deutsche Numis
Trading venue: London Stock Exchange
The purchased Shares will be cancelled.
Following the purchase of these Shares, the remaining number of Shares in
issue will be 403,309,411. The Company does not hold any Shares in treasury.
Therefore, the total number of voting rights in the Company is 403,309,411.
This figure may be used by shareholders as the denominator for the calculation
by which they can determine if they are required to notify their interest in,
or a change to their interest in, the Company under the FCA's Disclosure
Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms
part of domestic law of the United Kingdom by virtue of the European Union
(Withdrawal) Act 2018, the table below contains detailed information of the
individual trades made by Deutsche Numis as part of the Share Buyback
Programme:
Date of purchase Number of ordinary shares purchased Transaction price Time of transaction (UK Time) Transaction reference number Trading venue
(GBp share)
25 November 2024 551 220.00 08:06:17 00072560773TRLO0 XLON
25 November 2024 1090 219.50 08:06:39 00072560791TRLO0 XLON
25 November 2024 1498 219.50 08:06:39 00072560790TRLO0 XLON
25 November 2024 900 219.50 09:16:39 00072562020TRLO0 XLON
25 November 2024 247 219.50 09:16:39 00072562019TRLO0 XLON
25 November 2024 812 219.50 09:16:39 00072562018TRLO0 XLON
25 November 2024 200 219.50 09:16:39 00072562017TRLO0 XLON
25 November 2024 250 219.50 09:16:39 00072562016TRLO0 XLON
25 November 2024 100 219.50 09:16:39 00072562015TRLO0 XLON
25 November 2024 2179 219.50 09:29:53 00072562367TRLO0 XLON
25 November 2024 340 219.50 09:29:53 00072562366TRLO0 XLON
25 November 2024 268 219.50 10:30:16 00072563601TRLO0 XLON
25 November 2024 522 219.50 10:30:16 00072563600TRLO0 XLON
25 November 2024 3729 219.50 10:30:16 00072563599TRLO0 XLON
25 November 2024 694 219.00 10:38:36 00072563722TRLO0 XLON
25 November 2024 939 219.00 10:38:36 00072563721TRLO0 XLON
25 November 2024 939 219.00 10:38:36 00072563720TRLO0 XLON
25 November 2024 502 218.00 11:00:22 00072564226TRLO0 XLON
25 November 2024 195 218.00 11:11:02 00072564463TRLO0 XLON
25 November 2024 1960 218.00 12:02:01 00072566227TRLO0 XLON
25 November 2024 71 218.00 12:02:01 00072566226TRLO0 XLON
25 November 2024 10 218.00 12:02:01 00072566225TRLO0 XLON
25 November 2024 1314 217.50 12:04:41 00072566340TRLO0 XLON
25 November 2024 446 217.50 12:08:10 00072566539TRLO0 XLON
25 November 2024 370 217.50 12:08:10 00072566540TRLO0 XLON
25 November 2024 328 217.50 12:16:41 00072566903TRLO0 XLON
25 November 2024 937 217.50 12:45:26 00072567569TRLO0 XLON
25 November 2024 1302 217.50 12:45:26 00072567568TRLO0 XLON
25 November 2024 611 218.50 13:31:47 00072568782TRLO0 XLON
25 November 2024 900 218.50 13:31:47 00072568781TRLO0 XLON
25 November 2024 826 218.50 13:31:47 00072568780TRLO0 XLON
25 November 2024 2643 218.50 13:50:00 00072569093TRLO0 XLON
25 November 2024 541 218.50 13:52:27 00072569154TRLO0 XLON
25 November 2024 537 218.50 14:16:27 00072569821TRLO0 XLON
25 November 2024 508 218.50 14:16:27 00072569820TRLO0 XLON
25 November 2024 514 218.50 14:16:31 00072569826TRLO0 XLON
25 November 2024 515 218.50 14:16:31 00072569825TRLO0 XLON
25 November 2024 1386 218.50 14:32:31 00072570520TRLO0 XLON
25 November 2024 712 218.50 14:32:31 00072570519TRLO0 XLON
25 November 2024 810 218.00 14:32:36 00072570521TRLO0 XLON
25 November 2024 1147 218.00 14:32:37 00072570522TRLO0 XLON
25 November 2024 317 218.00 14:32:42 00072570524TRLO0 XLON
25 November 2024 1639 219.00 15:25:17 00072573291TRLO0 XLON
25 November 2024 1237 219.50 15:35:59 00072574063TRLO0 XLON
25 November 2024 1038 219.50 15:35:59 00072574062TRLO0 XLON
25 November 2024 407 219.50 15:35:59 00072574060TRLO0 XLON
This announcement will also be available on the Company's website at:
https://investors.spirehealthcare.com/news/regulatory-news/
Enquiries:
Spire Healthcare
Harbant Samra, CFO
+44 (0)7881 672 365
Instinctif Partners
Julian
Walker
+44 (0)7825 189 696
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number 09084066
About Spire Healthcare
Spire Healthcare (http://www.spirehealthcare.com/) is a leading independent
healthcare group in the United Kingdom, running 38 hospitals and over 50
clinics, medical centres and consulting rooms across England, Wales and
Scotland. It operates a network of private GPs and provides occupational
health services to over 800 corporate clients.
Working in partnership with over 8,600 experienced consultants, Spire
Healthcare delivered tailored, personalised care to over 1 million inpatients,
outpatients and daycase patients, and occupational health programme clients,
in 2023, and is the leading private provider, by volume, of knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
operations in the United Kingdom. It also delivers a range of private and NHS
mental health, musculoskeletal and dermatological services under the Vita
Health Group brand.
Spire Healthcare's well-located and scalable hospitals have delivered
successful and award-winning outcomes, positioning the group well with
patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI')
providers. 98% of Spire Healthcare's inspected locations are rated 'Good',
'Outstanding' or the equivalent by health inspectors in England, Wales and
Scotland.
Spire Healthcare is listed on the London Stock Exchange and is a member of the
FTSE 250.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSKELFLZFLZFBF